Carbapenems

The Pharmacokinetics and Pharmacodynamics of Meropenem in the Cerebrospinal Fluid of Neurosurgical Patients

(2014) R. Tsumura et al.   JOURNAL OF CHEMOTHERAPY

Optimal Meropenem Concentrations To Treat Multidrug-Resistant Pseudomonas aeruginosa Septic Shock

(2012) Fabio Silvio Taccone et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

(2012) R. Cantón et al.   CLINICAL MICROBIOLOGY AND INFECTION

Carbapenems: Past, Present, and Future

(2011) Krisztina M. Papp-Wallace et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli

(2011) M. Hombach et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Meta-analysis: ertapenem for complicated intra-abdominal infections

(2010) M. E. FALAGAS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pharmacokinetic-Pharmacodynamic-Model-Guided Doripenem Dosing in Critically Ill Patients

(2010) M. N. Samtani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Penetration of doripenem into prostatic tissue following intravenous administration in prostatectomy patients

(2010) Yoshiaki Yamada et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Multiplex Real-Time PCR Assay for Detection and Classification of Klebsiella pneumoniae Carbapenemase Gene (blaKPC) Variants

(2010) L. Chen et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Doripenem Pharmacokinetics in Critically Ill Patients Receiving Continuous Hemodiafiltration (CHDF)

(2010) Seigo HIDAKA et al.   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

Characteristics of doripenem: a new broad-spectrum antibiotic

(2010) Francisco Alvarez-Lerma   Drug Design Development and Therapy

Intravenous Doripenem at 500 Milligrams versus Levofloxacin at 250 Milligrams, with an Option To Switch to Oral Therapy, for Treatment of Complicated Lower Urinary Tract Infection and Pyelonephritis

(2009) K. G. Naber et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Doripenem

(2009) David L. Paterson et al.   CLINICAL INFECTIOUS DISEASES

Doripenem monohydrate, a broad-spectrum carbapenem antibiotic

(2009) S.James Matthews et al.   CLINICAL THERAPEUTICS

Pharmacokinetic issues for antibiotics in the critically ill patient

(2009) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Activity of a novel carbapenem, doripenem, against anaerobic pathogens

(2009) Ellie J.C. Goldstein et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Overview of Seizure-Inducing Potential of Doripenem

(2009) George G. Zhanel et al.   DRUG SAFETY

Doripenem: position in clinical practice

(2009) Harakh V Dedhia et al.   Expert Review of Anti-Infective Therapy

Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK

(2009) M. Doumith et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Relevance of resistance levels to carbapenems and integron-borne blaIMP-1, blaIMP-7, blaIMP-10 and blaVIM-2 in clinical isolates of Pseudomonas aeruginosa

(2009) W.-H. Zhao et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Disposition, Metabolism, and Excretion of [14C]Doripenem after a Single 500-Milligram Intravenous Infusion in Healthy Men

(2008) I. Cirillo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activities of Doripenem, a New Broad-Spectrum Carbapenem, against Recently Collected Clinical Anaerobic Isolates, with Emphasis on the Bacteroides fragilis Group

(2008) D. R. Snydman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and Pseudomonas aeruginosa

(2008) T. A. Davies et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Parenteral carbapenems

(2008) P.M. Shah   CLINICAL MICROBIOLOGY AND INFECTION

New developments in carbapenems

(2008) J.N. Kattan et al.   CLINICAL MICROBIOLOGY AND INFECTION

Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: A phase III, prospective, multicenter, randomized, double-blind, noninferiority study

(2008) Christopher Lucasti et al.   CLINICAL THERAPEUTICS

Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study

(2008) Álvaro Réa-Neto et al.   CURRENT MEDICAL RESEARCH AND OPINION

Doripenem

(2008) Susan J Keam   DRUGS

In vitro activity of doripenem against Acinetobacter baumannii clinical isolates

(2008) Sara Marti et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Ertapenem peritoneal fluid concentrations in adult surgical patients

(2008) Silvia Arrigucci et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results

(2007) Philip J. Turner   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis

(2007) Philipp Latzin et al.   Journal of Cystic Fibrosis